JWM
FENC icon

JPL Wealth Management’s Fennec Pharmaceuticals FENC Stock Holding History

JPL Wealth Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11 Buy
+1
New +$8 ﹤0.01% 1836

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JPL Wealth Management's FENC Position: Q2 2026 in Review

JPL Wealth Management opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 1 share worth $11. The stake represents ﹤0.01% of the portfolio and ranks #1836 among its holdings.

104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • JPL Wealth Management held 1 share of Fennec Pharmaceuticals worth $11 as of Q2 2026.
  • Fennec Pharmaceuticals was a new JPL Wealth Management position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1836 holding.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.